Nelson et al, I expect some of the whole virus
Post# of 147708
I expect some of the whole virus vaccines to gain a foothold, should they prove effective in trials.
They should elector a broader range of antibodies than antibodies specific to one spike protein conformation.
There is a potential that these could be effective against infection, not just severe disease manifestations.
Leronlimab of course may very well rule the roost after successful Brazilian and LH trials.